ERNEST AMUKAMARA: Open Payments
NPI 1356529101 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 25 payments from 6 companies in 2025. Trend: 2023 $242 · 2024 $153 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $213 |
| Merck Sharp & Dohme LLC | 8 | $149 |
| Novo Nordisk Inc | 3 | $71 |
| Exact Sciences Corporation | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $31 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: PIFELTRO, APRETUDE, CABENUVA, DOVATO, Ozempic, Wegovy, Cologuard Collection Kit, ERZOFRI EXTENDED-RELEASE.
Industry payments across GA — which companies pay providers there.
